SSwitzerland Read More AlpineAI raises double-digit million seed round for sovereign AI2026-04-14 Davos-based AlpineAI has raised a double-digit million seed round led by Swiss KMU Partners to scale its sovereign…
RRoche Read More Roche Faces Critical Week with MS Drug Data and Q1 Report2026-04-09 Roche stock faces pivotal week with Phase III MS drug safety data on April 22 and Q1 sales…
NNestlé Read More Shareholder Vote and Sales Data to Test New Strategy2026-04-09 Nestlé’s leadership navigates a critical AGM vote on governance and a key Q1 sales report, with its stock…
RRoche Read More Roche Faces Critical Week with MS Drug Data and Q1 Report2026-04-09 Roche stock faces pivotal week with Phase III MS drug safety data on April 22 and Q1 sales…
NNestlé Read More Shareholder Vote and Sales Data to Test New Strategy2026-04-08 Nestlé’s leadership navigates a critical AGM vote on governance and a key Q1 sales report, with its stock…
LLausanne Read More Governing AI in God’s house, Evangelical Focus2026-04-07 The growing number of AI-enabled Church Management Systems has raised awareness and renewed concerns around the use of…
NNovartis Read More Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%2026-03-29 – Novartis today announced final two-year results from the Phase III APPLAUSE‑IgAN study of Fabhalta® (iptacopan) in IgA…
AABB Read More TCS bets on AI-led growth with Amadeus, ABB partnerships2026-03-19 Indian IT major Tata Consultancy Services (TCS) on Thursday announced two strategic partnerships with Amadeus and ABB, as…
RRoche Read More Swiss Roche builds its own AI factory with NVIDIA – with Genentech in California2026-03-18 The planned AI factory will comprise more than 3,500 high-performance GPUs, making it the most powerful setup of…
RRoche Read More New England Journal of Medicine publishes phase III ALLEGORY data showing Roche’s Gazyva/Gazyvaro significantly reduces disease activity in the most common form of lupus2026-03-06 Over three quarters of people on Gazyva/Gazyvaro plus standard therapy achieved at least a four-point improvement in SRI-4,…
NNovartis Read More Is workplace inclusion really that important?2026-03-06 Inclusion is a vital part of our global culture at Novartis, with initiatives led at a country level…
GGeneva Read More AI safety: Brands need to more than simply comply2026-03-03 Forty eight prestigious brands showcase their creations at the Watches and Wonders annual fair in Geneva – Copyright…